I'm in the dark but assume normal treatment to March 31st then we have the big pharma push back kicking in from March 31st.
Hopefully SI educates them in turn on the Rux data showing its limitations. This may backfire on big pharma in the long term.
I think Rux comes off patent protection after 2026, so their gravy train has a limited window possibly.
- Forums
- ASX - By Stock
- MSB
- Ann: Ryoncil Highlighted at Tandem Transplantation Meetings
MSB
mesoblast limited
Add to My Watchlist
2.47%
!
$1.78

Ann: Ryoncil Highlighted at Tandem Transplantation Meetings, page-99
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.78 |
Change
-0.045(2.47%) |
Mkt cap ! $2.287B |
Open | High | Low | Value | Volume |
$1.80 | $1.83 | $1.76 | $6.632M | 3.713M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 23685 | $1.78 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.79 | 39794 | 49 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 27902 | 1.780 |
21 | 39924 | 1.775 |
12 | 35544 | 1.770 |
16 | 109743 | 1.765 |
10 | 64592 | 1.760 |
Price($) | Vol. | No. |
---|---|---|
1.785 | 37663 | 33 |
1.790 | 30120 | 12 |
1.795 | 51704 | 10 |
1.800 | 47204 | 9 |
1.805 | 93304 | 7 |
Last trade - 12.17pm 18/06/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online